|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pursuant to his Answer of 6th July, Official Report, column 368W, when the combined therapy auto-injector to combat the post-attack symptoms of nerve agent poisoning was issued for use by the armed forces; what antidotes can be used in the auto-injector and what is the effect of these antidotes; when the studies to develop the auto-injector took place with service volunteers; how many service volunteers took part in these studies; and what these studies entailed. - Includes fact that studies to develop this therapy have been conducted over many years, and to provide details of all the studies would involve disproportionate cost. |
|
|
|
|
|
35611 |
|
|
Ministry of Defence |
|
|
http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_293571 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|